New National Analysis Reveals Large Geographic Gaps in Detoxification Services

September 10, 2026 9:35 AM

A new national analysis from Treatment Locators found substantial geographic differences in the availability of addiction treatment facilities reporting detoxification services across the United States.Treatment Locators analyzed 11,513 facilities listed in Substance Abuse and Mental Health Services Administration data and identified 2,261 facilities - 19.6% - reporting detoxification services. Of those, 2,169 had usable geographic coordinates...

Read more

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

September 10, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that all randomized pediatric MVID patients in Napo's pivotal crossover clinical trial have entered the single-blind extension phase to receive blinded doses of crofelemer to support longer-term safety and efficacy for crofelemer powder for oral solution as adjunctive therapy to parenteral support (PS). The trial is ongoing at multiple centers...

Read more

AGS Health Recognized With Brandon Hall Group Silver HCM Learning and Development Excellence Award

September 10, 2026 9:00 AM

AGS Health®, a leading technology-first revenue cycle management (RCM) solutions provider serving U.S. healthcare providers through a comprehensive platform combining AI-driven solutions, data analytics, and specialized global delivery capabilities, has been recognized with a Brandon Hall Group Silver HCM Learning and Development Excellence Award. The company was recognized in the Best Certification Program category for its talent development...

Read more

Medical Care Technologies Inc. (OTCID:MDCE) Configures StrainScan Pro AI Vision Modules for High-Value Produce Categories

September 10, 2026 8:57 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced that StrainScan Pro is being configured for some of the most valuable and perishable crops in a global agriculture market estimated near $4.8 trillion to $5 trillion - leafy greens, berries, tomatoes, and tree fruit, where visual defects and spoilage can erase value in hours, not weeks. The platform is live for review at https://strainscanpro.com.StrainScan Pro is proprietary AI vision...

Read more

Updated COVID-19 Vaccines Available at CVS Pharmacy and MinuteClinic Across the U.S.

September 10, 2026 8:45 AM

CVS Health® (NYSE:CVS) announced that updated 2026-2027 COVID-19 vaccines are now available at CVS Pharmacy® and MinuteClinic® locations for patients at no-cost with most insurance plans. Appointments are available at CVS.com, MinuteClinic.com and through the CVS Health® app, and walk-ins are accepted at CVS Pharmacy and MinuteClinic."We know patients value having convenient access to the vaccines and preventive care services they need," said...

Read more

Clinical Maestro Launches Source Plus, the Intelligence Layer for Clinical Sourcing

September 10, 2026 8:37 AM

Clinical Maestro launches Source Plus, its next-generation intelligent sourcing solution for pharmaceutical and biotechnology organizations managing complex, high-value outsourced services.Clinical Maestro Launches Source Plus, the Intelligence Layer for Clinical Sourcing / Source: Clinical Maestro (EZ Newswire) Source Plus goes beyond traditional sourcing automation by combining Maestro AI, pharmaceutical domain intelligence, proven sourcing...

Read more

DaVita Community Care Report 2025: Our Journey to Net Zero

September 10, 2026 8:35 AM

2025 marked a proud moment for DaVita as we met our goal to power 100% of our global operations with renewable energy. We achieved this by securing multiple virtual power purchase agreements in the US and Europe over the past five years - offsetting our global energy consumption with renewable solar and wind power.This milestone was one of multiple environmental goals DaVita established five years ago and has met in the time since. This marks an...

Read more

Vheda Health Secures $47 Million Investment from Agora to Scale Outcomes and Analytics Platform for Health Plans

September 10, 2026 8:00 AM

Vheda Health, an outcomes and analytics company serving health plans' highest-risk and hardest-to-reach members, today announced a $47 million investment from Agora, a San Francisco-based private equity investment firm focused on healthcare and life science technology. The investment, which represents the first institutional capital in Vheda's 13-year history and the inaugural investment for Agora, will fund Vheda's continued national expansion...

Read more

Ascelia Pharma Completes FDA Type A Meeting on Orviglance NDA

September 10, 2026 1:45 AM

Ascelia Pharma (STO:ACE) completed the previously scheduled Type A meeting with the U.S. Food and Drug Administration (FDA) on September 9, 2026, regarding the Complete Response Letter (CRL) for the Orviglance® New Drug Application (NDA).The meeting provided an opportunity to discuss the issues raised by the FDA in the CRL and to gain further clarity regarding obtaining regulatory approval for Orviglance in the US. Ascelia will provide an update...

Read more

Marijuana Schedule III Escapes an Immediate Freeze-Now the Billion-Dollar Order Must Survive the Law

September 9, 2026 11:50 PM

The United States Court of Appeals for the District of Columbia Circuit has denied a request to suspend the federal government's limited marijuana Rescheduling Order while consolidated legal challenges brought by MMJ International Holdings and other petitioners proceed.The September 9 ruling means the existing order remains effective during judicial review. It does not uphold the order's legality, decide the merits of the petitioners' claims or...

Read more

NEOLISE Sculpt Review 2026: Could This Tesamorelin Program Be the Body-Recomposition Option GLP-1 Users are Looking Into Next?

September 9, 2026 10:00 PM

Title phrases including "Sculpt," "recomposition," and "the missing piece" reflect NEOLISE's own marketing language at neolise.com/sculpt. "Claim" in the title refers to this publication's characterization of that marketing language, not an assertion by NEOLISE. This publication does not independently substantiate any of it. Readers seeking verification context should continue reading. Any reference in this article to "review," "investigation,"...

Read more

GlycoReset Reviews 2026: Could This Blood Sugar Support Supplement Be the Daily Wellness Upgrade Your Routine Has Been Missing?

September 9, 2026 9:35 PM

Quick disclosure: this is a paid advertorial, and a commission is earned if you buy through the links here - product claims are attributed to the brand, not independently endorsed by this publication. This content is promotional and intended for consumer education about a commercially available product. GlycoReset is a dietary supplement, not a drug, not evaluated or approved by the FDA, and per the brand's own disclaimer, it's not meant to...

Read more

NEOLISE Longevity Reviews 2026: Could This CJC-1295 + Ipamorelin Protocol Be the Longevity Upgrade You've Been Looking For? Pricing & FDA Status Examined

September 9, 2026 9:00 PM

Advertorial. Quick disclosure: this is a paid advertorial. This content is promotional in nature and is intended for consumer education regarding a commercially available product. A commission is earned if you purchase through links here. Claims belong to the brand, not to this publication, and aren't independently endorsed. NEOLISE Longevity is a provider-prescribed compounded peptide protocol - not an over-the-counter product, and not...

Read more

NEOLISE Recovery Review 2026: Could This BPC-157/TB-500 Protocol Be the Recovery Upgrade You've Been Looking For? Price & FDA Status Examined

September 9, 2026 8:10 PM

PAID ADVERTISEMENT / ADVERTORIAL DISCLOSURE: This is paid promotional content and contains affiliate links. A commission is earned if you purchase through links in this article. Product claims are attributed to the brand and are not independently endorsed. NEOLISE Recovery is a compounded prescription peptide protocol (BPC-157 and TB-500) offered through an independent telehealth process. Neither BPC-157 nor TB-500 is FDA-approved for any use,...

Read more

NEOLISE Renewal Review 2026: Is This the 4-Peptide Prescription Pathway Adults Over 30 are Looking For? Formula, Price & FDA Context Examined

September 9, 2026 7:35 PM

Paid Advertorial: This sponsored article is advertising, not independent medical reporting, and a commission may be earned when purchases are made through sponsored links. NEOLISE Renewal is a prescription-dependent compounded peptide protocol, not a dietary supplement - compounded drugs aren't FDA-approved, and this review didn't identify FDA approval for GHK-Cu, BPC-157, TB-500, or KPV as used in this formulation. Product, pricing, process,...

Read more

DirectMax Apomorphine Review 2026: The Truth About Its FDA Status and What Patients Should Know

September 9, 2026 7:05 PM

Advertorial Disclosure: This is paid promotional content. A commission may be earned if you purchase through links in this article. DirectMax is a compounded prescription medication; access requires review and approval by a licensed healthcare provider when clinically appropriate, and approval is not guaranteed.The Truth About DirectMax's Apomorphine: 2026 FDA Update (Consumer Research)Apomorphine shows up in DirectMax's ad in one sentence,...

Read more

Transition of Fitzgibbon Hospital Operations Complete; American Medical Administrators Begins Management of Hospital and Related Healthcare Operations

September 9, 2026 6:55 PM

American Medical Administrators, Inc. ("AMA") today announced the completion of the transition of Fitzgibbon Hospital and related healthcare operations to new ownership and management following approval of the transaction by the U.S. Bankruptcy Court.Fitzgibbon Hospital, the Living Center Skilled Nursing Facility and the Fitzgibbon-operated Rural Health Clinics will remain open and continue serving patients and residents throughout the...

Read more

CVS Health Marks 20 Years of Free Community Health Screening Program As New Survey Reveals Many U.S. Adults Still Face Barriers to Preventive Health Screenings

September 9, 2026 11:00 AM

New survey findings commissioned by CVS Health® (NYSE:CVS) reveal that many Americans face persistent barriers accessing preventive health screenings. Nearly one in four adults have delayed speaking with a health professional about health concerns because of barriers related to access, cost or availability, and one-third were unaware that community screening programs exist."People aren't telling us that preventive health screenings don't matter;...

Read more

BetterWay(TM) Blood Testing Shows How U.S. Logistics Can Help Expand Access to Healthcare at Made in America Summit

September 9, 2026 10:47 AM

BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, will host an activation during the Made in America Summit on Thursday, September 10 from 12 pm - 5 pm. This activation is designed to spark conversation about the role logistics can play in addressing barriers to blood testing.Made in America is a two-day summit, hosted at STATION NWA in partnership with the...

Read more

ScienceSoft Expects 40% of Adults 55+ to Use AI-Powered Wearables for Health Alerts by 2030

September 9, 2026 10:35 AM

ScienceSoft has published a prediction article based on its proprietary research into the adoption of predictive AI-powered wearables among older adults. ScienceSoft forecasts that by 2030, around 40% of people aged 55 and older may use wearable devices powered by predictive AI to flag warning signs of serious health conditions. These could include both medical devices and consumer wearables, such as smartwatches. Rather than diagnosing...

Read more